Insider Trading

CRMD Stock  USD 7.34  3.43  31.85%   
About 58% of CorMedix's investor base is looking to short. The analysis of overall sentiment of trading CorMedix stock suggests that many investors are alarmed at this time. The current market sentiment, together with CorMedix's historical and current headlines, can help investors time the market. In addition, many technical investors use CorMedix stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by CorMedix Executive. Insider Public Trading

Read at macroaxis.com
CorMedix insider trading alert for general transaction of by Todisco Joseph, Executive, on 1st of May 2024. This event was filed by CorMedix with SEC on 2022-03-18. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

CorMedix's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the CorMedix's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

CorMedix Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards CorMedix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

CorMedix Maximum Pain Price Across June 20th 2025 Option Contracts

CorMedix's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of CorMedix close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of CorMedix's options.

CorMedix Fundamental Analysis

We analyze CorMedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CorMedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CorMedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

CorMedix is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

CorMedix Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CorMedix stock to make a market-neutral strategy. Peer analysis of CorMedix could also be used in its relative valuation, which is a method of valuing CorMedix by comparing valuation metrics with similar companies.

Peers

CorMedix Related Equities

CELCCelcuity LLC   3.24   
0%
28.0%
ELDNEledon Pharmaceuticals   2.85   
0%
24.0%
CNTBConnect Biopharma   1.25   
0%
10.0%
ALDXAldeyra   0.46   
0%
3.0%
NUVBNuvation Bio   1.02   
8.0%
0%
TVTXTravere Therapeutics   1.32   
11.0%
0%
TARSTarsus Pharmaceuticals   1.97   
17.0%
0%
APTOAptose Biosciences   2.25   
19.0%
0%
KRONKronos Bio   2.30   
19.0%
0%
REPLReplimune   3.26   
28.0%
0%
INBXInhibrx   3.40   
29.0%
0%
SGMOSangamo Therapeutics   3.45   
29.0%
0%
ABOSAcumen Pharmaceuticals   4.03   
34.0%
0%
ELVNEnliven Therapeutics   5.08   
44.0%
0%
PGENPrecigen   6.04   
52.0%
0%
ETONEton Pharmaceuticals   7.10   
61.0%
0%
GOSSGossamer Bio   7.91   
68.0%
0%
LYRALyra Therapeutics   11.11   
96.0%
0%
NVCTNuvectis Pharma   11.52   
100.0%
0%

Complementary Tools for CorMedix Stock analysis

When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets